Clinical Trial Update: Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 trial update for Hema-NeoTIL01 cell infusion therapy in relapsed/refractory acute leukemia, including acute myeloid leukemia and B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Hema-NeoTIL01 Cell Infusion Therapy (Hema-NeoTIL01)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Leukemia, Myeloid, Acute, B-cell Acute Lymphoblastic Leukemia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING